Search

everythinglearnresearchcommunity

for

Search:↓

The 1550 nm fractional Er:Glass laser improved hair regrowth in patients with androgenic alopecia, but didn't significantly change collagen type I, skin fibroblasts, or macrophages. More research is needed for optimal results.

Certain genes are linked to the quality of cashmere in goats.

Proteoglycan replacement therapy improved hair conditions in most patients with alopecia.

Tofacitinib taken by mouth helps treat hair loss in children.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

The document concludes that recent research has improved understanding of skin diseases and the balance between cell growth and differentiation in the epidermis.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

MARCKSL1 is important for wound healing and could be a target to reduce scarring.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Ch55 may help reduce skin scarring and fibrosis.

Troponin I may help detect heart problems in people with Androgenetic Alopecia.

TCM is an effective and safe treatment for primary cicatricial alopecias.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

RANKL helps regenerate lung cells, potentially aiding lung repair in diseases like COPD.

The study concluded that a protein important for hair strength is regulated by certain molecular processes and is affected by growth phases.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Goat skin has collagen, elastic, and reticular fibers, with hair follicles increasing in depth as goats age.

Clascoterone is safe for the heart, even at high doses.

The man's occipital hair loss was due to temporal triangular alopecia, not alopecia areata.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

The fascial layer is a promising new target for wound healing treatments using biomaterials.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Certain inflammatory molecules and leptin may contribute to hair loss in cicatricial alopecia.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Human anagen hair follicles have unique carbohydrate patterns during keratinization.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Overexpression of ALK2 in hair follicles disrupts skin development and slows wound healing.